SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Net income 2021–2025
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$8.3MFY2025 · since FY2021: -$8.2M → -$8.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.3M | -273.2% |
| FY2024 | $4.8M | +173.8% |
| FY2023 | -$6.5M | -12.1% |
| FY2022 | -$5.8M | +29.4% |
| FY2021 | -$8.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SCNI financial trends
SCNI RevenueSCNI Net marginSCNI Gross profitSCNI Gross marginSCNI Operating incomeSCNI Operating marginSCNI Operating cash flowSCNI Free cash flowSCNI Capital expendituresSCNI Return on equitySCNI Stock buybacksSCNI Dividends paidSCNI Total assetsSCNI Total liabilitiesSCNI Shareholders’ equitySCNI overview →